-+ 0.00%
-+ 0.00%
-+ 0.00%

IPO News | Puqi Pharmaceutical's Hong Kong Stock IPO Prospectus Expires

Zhitongcaijing·07/20/2026 23:09:02
Listen to the news

The Zhitong Finance App learned that the Hong Kong stock prospectus submitted by Beijing Puqi Pharmaceutical Technology Co., Ltd. (abbreviation: Puqi Pharmaceutical) on January 21, 2026 expired for 6 months and expired on July 21, 2026. CITIC Securities and Civil Bank Capital are co-sponsors.

image.png

According to the prospectus, Puqi Pharmaceutical is a biotech (Biotech) company focusing on the field of immune inflammation, and is committed to becoming a leader in targeted therapies for local delivery. Since its establishment in 2016, the company has been deeply involved in the treatment of chronic inflammatory diseases with innovative original design and accurate local delivery as its core capabilities, aiming to provide innovative solutions that combine efficacy, safety and long-term patient satisfaction.